Cargando…
eIF4A inhibition prevents the onset of cytokine-induced muscle wasting by blocking the STAT3 and iNOS pathways
Cachexia is a deadly muscle wasting syndrome that arises under conditions linked to chronic inflammation, such as cancer. Cytokines, including interferon γ (IFNγ), tumor necrosis factor α (TNFα) and interleukin-6 (IL-6), and their downstream effectors such as Signal Transducer and Activator of Trans...
Autores principales: | Cramer, Zvi, Sadek, Jason, Vazquez, Gabriela Galicia, Di Marco, Sergio, Pause, Arnim, Pelletier, Jerry, Gallouzi, Imed-Eddine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976662/ https://www.ncbi.nlm.nih.gov/pubmed/29849089 http://dx.doi.org/10.1038/s41598-018-26625-9 |
Ejemplares similares
-
Inducible nitric oxide synthase (iNOS) in muscle wasting syndrome, sarcopenia, and cachexia
por: Hall, Derek T., et al.
Publicado: (2011) -
Pharmacological or genetic inhibition of iNOS prevents cachexia‐mediated muscle wasting and its associated metabolism defects
por: Sadek, Jason, et al.
Publicado: (2021) -
Stress granules counteract senescence by sequestration of PAI‐1
por: Omer, Amr, et al.
Publicado: (2018) -
eIF4AII is dispensable for miRNA-mediated gene silencing
por: Galicia-Vázquez, Gabriela, et al.
Publicado: (2015) -
The AMPK agonist 5‐aminoimidazole‐4‐carboxamide ribonucleotide (AICAR), but not metformin, prevents inflammation‐associated cachectic muscle wasting
por: Hall, Derek T, et al.
Publicado: (2018)